Skip to main content
. 2020 Jun 5;34(Suppl 1):1–51. doi: 10.1038/s41433-020-0961-6

Table 3.

DRCR Network’s Protocol U study 24-week study results.

Change in vision Dexamethasone implant + ranibizumab Ranibizumab alone Adjusted difference p-value
≥10 letter improvement 22% 14% 6% p = 0.3
≥15 letter improvement 11% 2% 7% p = 0.03
≥10 letter loss 13% 6% 7% p = 0.09